Lisa Mendelson has been a nurse practitioner at the Boston University Amyloidosis Center since 2017. She obtained her nurse practitioner degree from MGH Institute of Health Professions in 2010 and prior to coming to BU worked in the San Francisco Bay Area in cardiology and hepatology. Before becoming a nurse practitioner Ms Mendelson was a registered nurse at McLean Psychiatric Hospital on their memory disorders unit, she also has extensive experience providing nursing care to frail homebound elders. In addition to her clinical practice she participates as a reviewer for multiple peer reviewed journals, is an active board member for Patient Discovery, International Symposium of Amyloidosis as well as Medical Dental Staff Clinician Council at BUMC. Ms Mendelson has authored multiple publications with a focus on amyloidosis awareness. She is the recipient of the BU Medical Group's 2019 clinical excellence award, 2024 National Daisy Award in Nursing, 2024 staff recognition award in the section of Hematology and Oncology.
Diversity, Equity, Inclusion and Accessibility
Initially I was annoyed at having to write a DEIA statement. As a mid level provider I do not have the power to tailor my practice or career the same as a physician. We are assigned what patients we will see and what research we participate in. Then I realized, I am actually annoyed at myself because it is my, not the institution’s responsibility to be mindful and ever cognizant of diversity, equity, inclusion and accessibility. Growing up I lived with refugee families from all over the world, we housed families while getting them set up with jobs, healthcare and housing. The racism and hurdles these families faced all was horrifying and I vowed to ensure that no matter what I did “when I grow up” I would be part of the solution. My previous employments focused on marginalized populations- home care for elderly, social worker for department of child and family, healthcare for the homeless…My current position does not and that is my fault. So thank you BU for making me write this statement and making me realize I have lost myself over the past few years and become complacent. I vow to do better in the future.
Member
Boston University
Amyloidosis Center
Publications listed below are automatically derived from MEDLINE/PubMed and other
sources, which might result in incorrect or missing publications. Faculty can
login
to make corrections and additions.
-
Ramireddy S, Prokaeva T, Chen H, Spencer B, Wong S, Dasari S, Dao L, McPhail ED, Sanchorawala V, Mendelson L. The Amyloidosis Intersection: Dual Amyloid Types in a Single Host. Eur J Haematol. 2025 Sep; 115(3):287-298.View Related Profiles. PMID: 40526008; DOI: 10.1111/ejh.14429;
-
Dodge MC, Prokaeva T, Mendelson L, Joshi T, Sanchorawala V, Kataria Y. High-Sensitivity and Conventional Cardiac Troponin-I Assays in AL Amyloidosis. J Appl Lab Med. 2025 Mar 03; 10(2):315-324.View Related Profiles. PMID: 39495058
-
Naiki H, Johnson M, Walters K, Carpinteiro A, Cibeira MT, D'Souza A, Kastritis E, Maurer MS, Mendelson L, Merlini G, Muchtar E, Palladini G, Riva E, Sekijima Y, Westermark P, Kumar S, Schönland SO. Global patterns of amyloid typing: results of a survey by the International Society of Amyloidosis (ISA). Amyloid. 2025 Jun; 32(2):139-144. PMID: 39928315
-
Sanchorawala V, Barroso B, Shelton A, Goetz E, Mendelson L, Joshi T, Burke N, Sloan JM, Staron A. Defying the odds: 30 years in AL amyloidosis research-recent barriers to clinical trial enrollment. Blood Adv. 2024 Nov 26; 8(22):5826-5828.View Related Profiles. PMID: 39293090; DOI: 10.1182/bloodadvances.2024014262;
-
Staron A, Mendelson LM, Joshi T, Burke N, Sanchorawala V. Factors impeding organ recovery despite a deep haematological response in patients with systemic AL amyloidosis. Br J Haematol. 2024 Dec; 205(6):2268-2272.View Related Profiles. PMID: 39275899
-
Anand SK, Staron A, Mendelson LM, Joshi T, Burke N, Sanchorawala V, Verma A. Machine-learning based subgroups of AL amyloidosis and cumulative incidence of mortality and end stage kidney disease. Am J Hematol. 2024 Nov; 99(11):2140-2151.View Related Profiles. PMID: 39257247; DOI: 10.1002/ajh.27472;
-
Gustine JN, Staron A, Mendelson L, Joshi T, Gopal DM, Siddiqi OK, Ruberg FL, Sanchorawala V. Predictors of treatment response and survival outcomes in patients with advanced cardiac AL amyloidosis. Blood Adv. 2023 Oct 24; 7(20):6080-6091.View Related Profiles. PMID: 37581513; DOI: 10.1182/bloodadvances.2023010324;
-
Gustine JN, Szalat RE, Staron A, Joshi T, Mendelson L, Sloan JM, Sanchorawala V. Light chain amyloidosis associated with Waldenström macroglobulinemia: treatment and survival outcomes. Haematologica. 2023 Jun 01; 108(6):1680-1684.View Related Profiles. PMID: 36546447; DOI: 10.3324/haematol.2022.282264;
-
Mendelson L, Prokaeva T, Lau KHV, Sanchorawala V, McCausland K, Spencer B, Dasari S, McPhail ED, Kaku MC. Hereditary gelsolin amyloidosis: a rare cause of cranial, peripheral and autonomic neuropathies linked to D187N and Y447H substitutions. Amyloid. 2023 Dec; 30(4):357-363.View Related Profiles. PMID: 37140928
-
Showing 10 of 22 results.
Show More
-
Alreshq R, Cozzolino M, Lilleness B, Pipilas A, Mendelson L, Joshi T, Muralidhar V, Guardino E, Berk JL, Siddiqi OK, Gopal DM, Sanchorawala V, Ruberg FL. Light Chain Testing Abnormalities Among Patients With Transthyretin Amyloid Cardiomyopathy Referred for Technetium-99m Pyrophosphate Imaging. Am J Cardiol. 2022 Oct 15; 181:105-112.View Related Profiles. PMID: 36028388; DOI: 10.1016/j.amjcard.2022.06.064;
-
Fogaren T, Shelton AC, Faller DV, Stull DM, Thuenemann S, Mendelson L. Understanding Amyloidosis: Unraveling the Complexities and Therapeutic Approaches for Oncology Nurses. Clin J Oncol Nurs. 2022 Jul 25; 26(4):421-432. PMID: 35939729
-
Gustine JN, Staron A, Szalat RE, Mendelson LM, Joshi T, Ruberg FL, Siddiqi O, Gopal DM, Edwards CV, Havasi A, Kaku M, Lau KHV, Berk JL, Sloan JM, Sanchorawala V. Predictors of hematologic response and survival with stem cell transplantation in AL amyloidosis: A 25-year longitudinal study. Am J Hematol. 2022 Sep; 97(9):1189-1199.View Related Profiles. PMID: 35731907
-
Mendelson L, Sanchorawala V, Connors L, Joshi T, Doros G, Pogrebinsky A, Havasi A. Correlation Between 24-Hour Urine Protein and Random Urine Protein-Creatinine Ratio in Amyloid Light-Chain Amyloidosis. Kidney Med. 2022 Apr; 4(4):100427.View Related Profiles. PMID: 35342879; DOI: 10.1016/j.xkme.2022.100427;
-
Staron A, Zheng L, Doros G, Connors LH, Mendelson LM, Joshi T, Sanchorawala V. Marked progress in AL amyloidosis survival: a 40-year longitudinal natural history study. Blood Cancer J. 2021 08 04; 11(8):139.View Related Profiles. PMID: 34349108; DOI: 10.1038/s41408-021-00529-w;
-
Schulman A, Connors LH, Weinberg J, Mendelson LM, Joshi T, Shelton AC, Sanchorawala V. Patient outcomes in light chain (AL) amyloidosis: The clock is ticking from symptoms to diagnosis. Eur J Haematol. 2020 Oct; 105(4):495-501.View Related Profiles. PMID: 32564450; DOI: 10.1111/ejh.13472;
-
-
Hwa L, Fogaren T, Faller D, Stuller D, Thuenemann S, Mendelson, L
. L Immunoglobulin Light-chain
Amyloidosis: Clinical Presentations and Diagnostic Approach. Journal of the Advanced Practitioner in Oncology. 2020; 4(11):395-400. View Publication
-
Staron A, Connors LH, Ruberg FL, Mendelson LM, Sanchorawala V. A new era of amyloidosis: the trends at a major US referral centre. Amyloid. 2019 Dec; 26(4):192-196.View Related Profiles. PMID: 31306033
-
Hwa YL, Fogaren T, Sams A, Faller DV, Stull DM, Thuenemann S, Mendelson L. Immunoglobulin Light-Chain Amyloidosis: Clinical Presentations and Diagnostic Approach. J Adv Pract Oncol. 2019 Jul; 10(5):470-481. PMID: 33457060; DOI: 10.6004/jadpro.2019.10.5.5;
-
Nguyen VP, Rosenberg A, Mendelson LM, Comenzo RL, Varga C, Sanchorawala V. Outcomes of patients with AL amyloidosis and low serum free light chain levels at diagnosis. Amyloid. 2018 Sep; 25(3):156-159.View Related Profiles. PMID: 30032640
-
Nguyen VP, Landau H, Quillen K, Brauneis D, Shelton AC, Mendelson L, Rahman H, Sloan JM, Sarosiek S, Sanchorawala V. Modified High-Dose Melphalan and Autologous Stem Cell Transplantation for Immunoglobulin Light Chain Amyloidosis. Biol Blood Marrow Transplant. 2018 09; 24(9):1823-1827.View Related Profiles. PMID: 29933072; DOI: 10.1016/j.bbmt.2018.06.018;
This graph shows the total number of publications by year, by first, middle/unknown,
or last author.
| Year | Publications |
|---|
| 2018 | 2 |
| 2019 | 2 |
| 2020 | 3 |
| 2021 | 1 |
| 2022 | 4 |
| 2023 | 4 |
| 2024 | 3 |
| 2025 | 3 |
2024 Boston Medical Center :
Daisy National Award in Nursing
2024 BMC Section of Hematology and Oncology :
Staff Recognition Award
2022 BUMG:
Faculty excellence award
2019 Boston University Medical Group :
Advanced Practice Provider Excellence
2010 MGH Institute of Health Professions:
Sigma Theta Tau Honor Society
2006 Ethos Homecare :
Clinician Excellence Award
2003 Old Colony YMCA :
Excellence Award
2002 Emmanuel College:
Magna Cum Laude